What are the normal and optimal thyroid‑stimulating hormone (TSH) and free thyroxine (Free T4) levels for women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal versus Optimal Thyroid Numbers for Women

For non-pregnant women, the normal TSH range is 0.45-4.12 mIU/L based on NHANES III data, though the optimal range appears to be narrower, with TSH values between the 60th-80th percentiles (approximately 1.90-2.90 mIU/L) associated with the lowest cardiovascular and mortality risk 1, 2.

Non-Pregnant Women

TSH Reference Ranges

The established normal range is 0.45-4.12 mIU/L 1. However, this range has been controversial:

  • The mean and median TSH in healthy populations cluster around 1.5 mIU/L, much closer to the lower limit than the upper limit 1
  • Some experts have proposed lowering the upper limit to 2.5-3.0 mIU/L, but data supporting treatment in the 2.5-4.12 mIU/L range are lacking outside of pregnancy 1
  • A 2023 meta-analysis of 134,346 participants found that TSH in the 60th-80th percentiles (median 1.90-2.90 mIU/L) was associated with the lowest risk of cardiovascular disease and mortality, suggesting this may represent the "optimal" range 2

Free T4 Reference Ranges

Normal Free T4 varies by assay method and should be laboratory-specific 3. When available:

  • The 2023 meta-analysis found FT4 in the 20th-40th percentiles (median 13.5-14.8 pmol/L) conveyed the lowest cardiovascular and mortality risk 2
  • FT4 above the 85th percentile in women over 70 years was associated with >5% increased 10-year absolute risk of cardiovascular events and mortality 2
  • FT4 should not be used as a therapeutic endpoint by itself when TSH is in the normal range 1

Pregnant Women

Critical Trimester-Specific Differences

Pregnancy dramatically alters thyroid function test interpretation, requiring trimester-specific ranges 3, 1, 3:

TSH in Pregnancy

First trimester: Upper limit 2.5 mIU/L (lower limit 0.1-0.2 mIU/L below non-pregnant range) 3, 1, 3

Second trimester: Upper limit 3.0 mIU/L 1, 3

Third trimester: Upper limit 3.5 mIU/L 1, 3

The lower TSH in early pregnancy results from the thyrotropic activity of elevated human chorionic gonadotropin (hCG) 3. A TSH within the classical 0.4-4.0 mIU/L range might actually represent hypothyroidism in the first trimester 3.

Free T4 in Pregnancy

Total T4 rises to approximately 150% of non-pregnant range due to estrogen-induced elevation of thyroid binding globulin 3. For Free T4:

  • Pregnancy-specific reference ranges must be established for each assay 3
  • Manufacturer reference ranges based on non-pregnant sera are not valid during pregnancy 3
  • As an alternative, multiply the non-pregnant total T4 range (50-150 nmol/L) by 1.5-fold for second and third trimesters 3

Key Clinical Pitfalls

TSH variability: Individual TSH measurements can vary up to 50% above or below a person's mean value on any given day 1. This biological variation means a single borderline value requires confirmation.

Individuality index: Both TSH and FT4 show high individuality (II <0.6 for FT4, 0.84 for TSH), meaning reference change values (RCV) should be preferred over population-based ranges when monitoring individuals 4. For TSH, a change of -40% to +68% is needed to be significant; for FT4, -13% to +15% 4.

Preconception planning: Women with known hypothyroidism planning pregnancy should have TSH adjusted to ≤2.5 mIU/L before conception 3, as thyroid hormone requirements increase 30-50% by 4-6 weeks gestation 3.

Assay-specific differences: Different immunoassay platforms produce different results. Each laboratory should establish its own reference intervals or verify manufacturer ranges 5, 6, 7.

References

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Related Questions

What are the recommended thyroid‑stimulating hormone (TSH) and free thyroxine (Free T4) target ranges for treating hypothyroidism in Canada, including adjustments for pregnancy and patients aged 65 years or older?
For routine health screening, is it more appropriate to order only thyroid stimulating hormone (TSH) or both TSH and free thyroxine (free T4)?
What are the normal reference ranges for thyroid function tests in adults?
According to NICE guidelines and UK practice, how should hypothyroidism be managed in a patient over 65 years old with a thyroid‑stimulating hormone level below 10 mU/L, normal free thyroxine, and symptoms of hypothyroidism?
What is the diagnosis and treatment for a 16‑year‑old female with markedly elevated thyroid‑stimulating hormone and low‑normal triiodothyronine and thyroxine levels?
What is the appropriate management of gallbladder stones in a child with sickle cell disease?
Is a comminuted nasal bone fracture with an abrasion classified as an open fracture?
Should fiber intake be avoided during an acute diverticulitis flare, but continued in uncomplicated diverticulosis?
What is the appropriate dosing schedule for candesartan 32 mg in an adult—should it be taken once daily or split into 16 mg twice daily?
What is the appropriate medication regimen for managing an acute gout flare in an elderly patient, including considerations for renal function, diabetes, and drug interactions?
Is there any indication to keep a patient with pancreatic cancer nil per os (NPO)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.